Haigh J R, Feely M
University Department of Medicine, University of Leeds, U.K.
Eur J Pharmacol. 1988 Mar 1;147(2):283-5. doi: 10.1016/0014-2999(88)90788-1.
The development of anticonvulsant tolerance with RO 16-6028, a benzodiazepine receptor partial agonist, was assessed in mice using an i.v. infusion of pentylenetetrazol as the convulsive stimulus. In contrast to other benzodiazepines tested previously in this seizure model the anticonvulsant protection afforded by RO 16-6028 did not change significantly during 10 days treatment (2 mg/kg b.i.d.). This result supports the hypothesis that partial agonists at the benzodiazepine receptor may induce less tolerance and/or dependence than full agonists.
使用静脉注射戊四氮作为惊厥刺激,在小鼠中评估了苯二氮䓬受体部分激动剂RO 16 - 6028的抗惊厥耐受性发展情况。与此前在该癫痫模型中测试的其他苯二氮䓬类药物不同,RO 16 - 6028提供的抗惊厥保护作用在10天治疗(2mg/kg,每日两次)期间没有显著变化。这一结果支持了以下假设:苯二氮䓬受体部分激动剂可能比完全激动剂诱导的耐受性和/或依赖性更低。